Published in Proc Natl Acad Sci U S A on November 01, 1974
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest (2000) 3.51
Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med (1978) 2.99
Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci U S A (1989) 2.65
Crystal structure of bovine Cu,Zn superoxide dismutase at 3 A resolution: chain tracing and metal ligands. Proc Natl Acad Sci U S A (1975) 2.61
Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med (1994) 2.44
Three-dimensional structure of an intact human immunoglobulin. Proc Natl Acad Sci U S A (1977) 2.23
Antigen-binding mutants of mouse myeloma cells. Proc Natl Acad Sci U S A (1977) 2.04
Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells. J Exp Med (1986) 2.04
Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc Natl Acad Sci U S A (1990) 1.99
Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice. J Exp Med (1975) 1.94
Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions. Proc Natl Acad Sci U S A (1979) 1.89
Secondary, tertiary, and quaternary structure of T-cell-specific immunoglobulin-like polypeptide chains. Proc Natl Acad Sci U S A (1986) 1.81
Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence. Proc Natl Acad Sci U S A (1975) 1.76
Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A (1982) 1.46
Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc Natl Acad Sci U S A (1981) 1.41
Structural invariants of antigen binding: comparison of immunoglobulin VL-VH and VL-VL domain dimers. Proc Natl Acad Sci U S A (1985) 1.32
Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes. Immunology (2001) 1.30
Self-association of human immunoglobulin kappa I light chains: role of the third hypervariable region. Proc Natl Acad Sci U S A (1980) 1.29
Mechanisms of antibody diversity: multiple genes encode structurally related mouse kappa variable regions. Proc Natl Acad Sci U S A (1978) 1.28
Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins. Proc Natl Acad Sci U S A (1976) 1.27
The structural repertoire of the human V kappa domain. EMBO J (1995) 1.26
A single amino acid substitution in the variable region of the light chain specifically blocks immunoglobulin secretion. Proc Natl Acad Sci U S A (1990) 1.21
Polymorphism in anti-phosphocholine antibodies reflecting evolution of immunoglobulin families. J Exp Med (1983) 1.21
Subgroups of variable region genes of beta chains of T-cell receptors for antigen. Proc Natl Acad Sci U S A (1986) 1.21
Clonal nature of the immune response to phosphorylcholine (PC). V. Cross-idiotypic specificity among heavy chains of murine anti-PC antibodies and PC-binding myeloma proteins. J Exp Med (1975) 1.20
Evidence supporting somatic assembly of the DNA segments (minigenes), coding for the framework, and complementarity-determining segments of immunoglobulin variable regions. J Exp Med (1979) 1.19
The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315. Biochem J (1977) 1.17
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci U S A (2013) 1.16
Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells. J Exp Med (1982) 1.14
Complete amino acid sequence of a mouse immunoglobulin alpha chain (MOPC 511). Proc Natl Acad Sci U S A (1980) 1.11
Similarities among hypervariable segments of immunoglobulin chains. Proc Natl Acad Sci U S A (1975) 1.10
A quantitative approach to sequence comparisons of nitrogenase MoFe protein alpha- and beta-subunits including the newly sequenced nifK gene from Klebsiella pneumoniae. Biochem J (1987) 1.10
Characterization of somatically mutated S107 VH11-encoded anti-DNA autoantibodies derived from autoimmune (NZB x NZW)F1 mice. J Exp Med (1991) 1.10
Variability of three-dimensional structure in immunoglobulins. Proc Natl Acad Sci U S A (1975) 1.09
Sequence variation among heavy chains from inulin-binding myeloma proteins. Proc Natl Acad Sci U S A (1978) 1.06
Functional antibody lacking a variable-region disulfide bridge. Proc Natl Acad Sci U S A (1986) 1.04
Attempts to locate residues in complementarity-determining regions of antibody combining sites that make contact with antigen. Proc Natl Acad Sci U S A (1976) 1.02
Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen. J Exp Med (1992) 1.01
Dual conformations of an immunoglobulin light-chain dimer: heterogeneity of antigen specificity and idiotope profile may result from multiple variable-domain interaction mechanisms. Proc Natl Acad Sci U S A (1988) 1.01
Do active site conformations of small ligands correspond to low free-energy solution structures? J Comput Aided Mol Des (1998) 0.99
Recognition and interactions controlling the assemblies of beta barrel domains. Biophys J (1986) 0.99
Modelling of the combining sites of three anti-lysozyme monoclonal antibodies and of the complex between one of the antibodies and its epitope. EMBO J (1986) 0.99
Kappa-chain allotypes and isotypes in the rabbit: cDNA sequences of clones encoding b9 suggest an evolutionary pathway and possible role of the interdomain disulfide bond in quantitative allotype expression. Proc Natl Acad Sci U S A (1984) 0.95
Human and murine phosphorycholine-binding immunoglobulins: conserved subgroup and first hypervariable region of heavy chains. Proc Natl Acad Sci U S A (1976) 0.93
Structural implications of sequence variability in immunoglobulins. Proc Natl Acad Sci U S A (1977) 0.93
Nucleotide sequences of five anti-lysozyme monoclonal antibodies. EMBO J (1985) 0.93
A small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells. Proc Natl Acad Sci U S A (1982) 0.93
Crystal structure of the antigen-binding fragment of the murine anti-arsonate monoclonal antibody 36-71 at 2.9-A resolution. Proc Natl Acad Sci U S A (1990) 0.92
Antibody combining sites can be mimicked synthetically. Surface-simulation synthesis of the phosphorylcholine-combining site of myeloma protein M-603. Biochem J (1980) 0.91
Diversity at the variable-joining region boundary of lambda light chains has a pronounced effect on immunoglobulin ligand-binding activity. Proc Natl Acad Sci U S A (1984) 0.91
Amino acids at the site of V kappa-J kappa recombination not encoded by germline sequences. J Exp Med (1987) 0.91
Ig Constant Region Effects on Variable Region Structure and Function. Front Microbiol (2016) 0.90
Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments. Mol Immunol (2008) 0.90
Amino acid sequence of the Fv region of a human monoclonal IgM (protein WEA) with antibody activity against 3,4-pyruvylated galactose in Klebsiella polysaccharides K30 and K33. Proc Natl Acad Sci U S A (1983) 0.90
A monoclonal antibody that defines an idiotope with two subsites in galactan-binding myeloma proteins. J Exp Med (1981) 0.89
Crystal structure of galactan-binding mouse immunoglobulin J539 Fab at 4.5-A resolution. Proc Natl Acad Sci U S A (1979) 0.89
Secondary structure of the immunoglobulin J chain. Proc Natl Acad Sci U S A (1985) 0.89
Amino acid sequence of the first 217 residues of a mouse heavy chain (MOPC 47A) with a domain deletion. Proc Natl Acad Sci U S A (1977) 0.88
Nucleotide sequences and three-dimensional modelling of the VH and VL domains of two human monoclonal antibodies specific for the D antigen of the human Rh-blood-group system. Biochem J (1990) 0.88
Insights into antibody catalysis: structure of an oxygenation catalyst at 1.9-angstrom resolution. Proc Natl Acad Sci U S A (1996) 0.86
Crystallographic studies of bovine beta2-microglobulin. Proc Natl Acad Sci U S A (1977) 0.86
Evolutionary and structural influences on light chain constant (CL) region of human and mouse immunoglobulins. Proc Natl Acad Sci U S A (1975) 0.86
Constancy of amino-terminal amino-acid sequences of antibodies of defined specificity and shared idiotype from individual inbred mice. Proc Natl Acad Sci U S A (1975) 0.86
Immunoglobulin with complementary paratope and idiotope. J Exp Med (1986) 0.86
Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase. J Virol (1994) 0.86
Chemical synthesis of idiotopes. Evidence that antisera to the same JH1 peptide detect multiple binding site-associated idiotopes. J Exp Med (1984) 0.85
Three distinct epitopes within the loop region of hen egg lysozyme defined with monoclonal antibodies. EMBO J (1985) 0.85
Some sequence similarities among cloned mouse DNA segments that code for lambda and kappa light chains of immunoglobulins. Proc Natl Acad Sci U S A (1979) 0.85
Some correlations between specificity and sequence of the first complementarity-determining segments of human kappa light chains. Proc Natl Acad Sci U S A (1976) 0.80
Monoclonal phosphorylcholine antibody binds to beta-lipoprotein from different animal species. Infect Immun (1986) 0.79
The structural basis of repertoire shift in an immune response to phosphocholine. J Exp Med (2000) 0.79
Specificity of mouse hybridoma antibodies to DNA. III. Antigenic determinants of nucleic acids recognized by poly(dG) specific monoclonal antibodies. Clin Exp Immunol (1985) 0.79
Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region. Biophys J (1996) 0.78
Engineered hapten-binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload delivery. Immunol Rev (2016) 0.78
Proline-rich tandem repeats of antibody complementarity-determining regions bind and neutralize human immunodeficiency virus type 1 particles. J Virol (1996) 0.75
Structure-function relations in phosphorylcholine-binding mouse myeloma proteins. Proc Natl Acad Sci U S A (1977) 0.75
cDNA of the immunoglobulin kappa chain of an Epstein-Barr virus-transformed human lymphoid cell line: partial sequence determination and bacterial expression. Proc Natl Acad Sci U S A (1985) 0.75
An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med (1970) 9.83
Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units. Biopolymers (1968) 6.54
The covalent structure of an entire gammaG immunoglobulin molecule. Proc Natl Acad Sci U S A (1969) 5.90
Immunoglobulin-producing tumors and myeloma proteins of mice. Physiol Rev (1972) 4.63
Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med (1974) 3.64
The matching of physical models to three-dimensional electron-density maps: a simple optical device. J Mol Biol (1968) 3.30
Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2,8-A resolution. Proc Natl Acad Sci U S A (1973) 3.14
The complete amino acid sequence of a mouse kappa light chain. Biochem J (1972) 2.94
Mechanism of antibody synthesis: size differences between mouse kappa chains. Science (1967) 2.77
Antigen-binding myeloma proteins in mice. Ann N Y Acad Sci (1971) 2.33
Structure of a lambda-type Bence-Jones protein at 3.5-A resolution. Biochemistry (1973) 2.29
The three dimensional structure of a combining region-ligand complex of immunoglobulin NEW at 3.5-A resolution. Proc Natl Acad Sci U S A (1974) 1.97
Immunoglobulin structure: amino terminal sequences of mouse myeloma proteins that bind phosphorylcholine. Science (1974) 1.94
Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. Eur J Biochem (1974) 1.76
Structure at 4.5 A resolution of a phosphorylcholine-binding fab. Nat New Biol (1973) 1.60
Variable region sequences of five human immunoglobulin heavy chains of the VH3 subgroup: definitive identification of four heavy chain hypervariable regions. Proc Natl Acad Sci U S A (1974) 1.52
Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity. Proc Natl Acad Sci U S A (1974) 1.36
Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis. Proc Natl Acad Sci U S A (1972) 1.34
Contact regions for dinitrophenyl and menadione haptens in an immunoglobulin binding more than one antigen. Proc Natl Acad Sci U S A (1972) 1.32
Variable region sequence of the heavy chain from a phosphorylcholine binding myeloma protein. Biochemistry (1974) 1.31
Changes of the conformation of rabbit IgG antibody caused by the specific binding of a hapten. X-ray small-angle studies. Eur J Biochem (1974) 1.00
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther (1999) 7.96
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science (1998) 7.89
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science (1994) 6.69
Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03
Conformations of immunoglobulin hypervariable regions. Nature (1990) 5.31
Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein. J Virol (1978) 5.12
Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A (1989) 5.10
Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. Biochemistry (1968) 4.83
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol (1996) 4.83
Immunoglobulin-producing tumors and myeloma proteins of mice. Physiol Rev (1972) 4.63
Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline. J Exp Med (1970) 4.49
Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell (2001) 4.44
Three classes of cell surface receptors for alphaherpesvirus entry. Virology (2000) 4.41
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity (1998) 4.23
Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. J Mol Biol (1986) 4.16
Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol (2001) 4.05
Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J Virol (1980) 3.95
Pseudomembranous colitis. J Clin Pathol (1977) 3.93
Antibody-antigen complexes. Annu Rev Biochem (1990) 3.91
Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature (1984) 3.80
Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med (1974) 3.64
Antigen-binding myeloma proteins of mice. Adv Immunol (1977) 3.54
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
Interactions of protein antigens with antibodies. Proc Natl Acad Sci U S A (1996) 3.53
Three-dimensional structure of the tryptophan synthase alpha 2 beta 2 multienzyme complex from Salmonella typhimurium. J Biol Chem (1988) 3.52
X-ray fiber diffraction and model-building study of polyguanylic acid and polyinosinic acid. J Mol Biol (1975) 3.50
Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci U S A (1987) 3.48
Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol (2001) 3.45
Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature (1988) 3.44
Structural basis of antibody function. Annu Rev Immunol (1983) 3.41
Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. Science (1992) 3.36
A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science (1986) 3.28
Evidence for the linkage of the IGC H locus to a gene controlling the idiotypic specificity of anti-p-azophenylarsonate antibodies in strain A mice. J Exp Med (1973) 3.18
Genetics of immunoglobulins in the mouse. Adv Immunol (1967) 3.14
Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12
Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. J Virol (1972) 3.11
Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc Natl Acad Sci U S A (1977) 3.07
Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol (1997) 3.05
Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. J Natl Cancer Inst (1972) 3.01
Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol (1996) 3.01
Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J Virol (1998) 3.00
Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production. J Virol (1980) 2.99
Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc Natl Acad Sci U S A (1998) 2.98
The two-component, ATP-dependent Clp protease of Escherichia coli. Purification, cloning, and mutational analysis of the ATP-binding component. J Biol Chem (1988) 2.95
Rapid viral induction of plasmacytomas in pristane-primed BALB-c mice. Science (1973) 2.94
Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1. J Virol (1980) 2.94
Nonrandom chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas. Cell (1979) 2.92
Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones. Nature (1980) 2.82
A novel DNA-binding motif in MarA: the first structure for an AraC family transcriptional activator. Proc Natl Acad Sci U S A (1998) 2.77
Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors. J Immunol (1977) 2.74
Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol (1985) 2.71
Sequence and structure of Clp P, the proteolytic component of the ATP-dependent Clp protease of Escherichia coli. J Biol Chem (1990) 2.71
Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol (1982) 2.71
Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc Natl Acad Sci U S A (1999) 2.69
Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. J Virol (1989) 2.68
Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2. J Virol (1980) 2.65
Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci U S A (1989) 2.65
Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. J Virol (1982) 2.62
Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell (1985) 2.59
Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol Cell Biol (1986) 2.57
DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science (1983) 2.40
Major urinary protein complex of normal mice: origin. Science (1965) 2.39
The three-dimensional structure at 6 A resolution of a human gamma Gl immunoglobulin molecule. J Biol Chem (1971) 2.38
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36
Antigen-binding myeloma proteins in mice. Ann N Y Acad Sci (1971) 2.33
Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science (1984) 2.28
Deoxyribonucleic acid synthesis in synchronized mammalian KB cells infected with herpes simplex virus. J Virol (1971) 2.25
Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol (1995) 2.24
Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex virus. J Virol (1972) 2.23
Three-dimensional structure of an intact human immunoglobulin. Proc Natl Acad Sci U S A (1977) 2.23
Oligomeric structure of glycoproteins in herpes simplex virus type 1. J Virol (1996) 2.22
Three IgA myeloma immunoglobulins from the BALB/ mouse: precipitation with pneumococcal C polysaccharide. Science (1968) 2.20
Idiopathic and drug-induced ulceration of the small intestine. Br J Surg (1970) 2.19
Interactions of vesicular stomatitis virus structural proteins with HeLa plasma membranes. Nat New Biol (1971) 2.19
Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus. Proc Natl Acad Sci U S A (1983) 2.16
Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. Microb Pathog (1987) 2.15
Synthesis, surface deposition, and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines. Cell (1975) 2.13
Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol (1998) 2.11
Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1. J Virol (1979) 2.10
Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc Natl Acad Sci U S A (1995) 2.09
Purification and properties of bovine thymosin. Ann N Y Acad Sci (1975) 2.08
The origin of the oxidative burst in plants. Free Radic Res (1995) 2.08
The molecular basis of substrate channeling. J Biol Chem (1999) 2.06
Structural conservation in parallel beta/alpha-barrel enzymes that catalyze three sequential reactions in the pathway of tryptophan biosynthesis. Biochemistry (1991) 2.06
Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. J Virol (1996) 2.05
The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J Virol (1999) 2.03